- How Each Medication Works
- Montelukast vs Cetirizine: Comparison Table
- Effectiveness for Allergic Rhinitis
- Effectiveness for Asthma
- Side Effects Comparison
- Cetirizine Side Effects
- Montelukast Side Effects and the FDA Boxed Warning
- Who Should Use Which Medication?
- Frequently Asked Questions
- Can I take montelukast and cetirizine together?
- Is montelukast stronger than cetirizine?
- Should I stop montelukast because of the boxed warning?
- Does cetirizine work right away while montelukast takes days?
- The Bottom Line
- Sources
Allergy sufferers often try multiple medications before finding relief, and the montelukast vs cetirizine comparison highlights two fundamentally different approaches to controlling allergic symptoms. Cetirizine (Zyrtec) is a widely available over-the-counter (OTC) antihistamine, while montelukast (Singulair) is a prescription-only leukotriene receptor antagonist that carries an FDA boxed warning which has changed how doctors prescribe it. These medications work through entirely different pathways, and understanding those differences — and the safety issues — matters for choosing the right treatment with your clinician. Explore more comparisons in our medical conditions guide.
How Each Medication Works
Cetirizine is a second-generation antihistamine. When you encounter an allergen, your body releases histamine, which binds to H1 receptors and triggers sneezing, itching, runny nose, and watery eyes. Cetirizine blocks these H1 receptors, preventing histamine from causing symptoms. It typically works within about 20–60 minutes of ingestion and provides relief for roughly 24 hours. It is sold over the counter, and you should follow the directions on the OTC Drug Facts label or your pharmacist’s advice.
Montelukast works through a completely different mechanism. Instead of blocking histamine, it blocks leukotrienes, which are inflammatory chemicals produced by immune cells in response to allergens and other triggers. Leukotrienes contribute to airway inflammation, bronchoconstriction, and mucus production. By blocking the cysteinyl leukotriene receptor (CysLT1), montelukast reduces inflammation in both the nasal passages and the lungs. This is why it can be useful for both allergic rhinitis and asthma — a dual role cetirizine cannot fill. Montelukast is available by prescription only, and how and when to take it is determined by your prescriber.
Montelukast vs Cetirizine: Comparison Table
| Feature | Montelukast (Singulair) | Cetirizine (Zyrtec) |
|---|---|---|
| Drug class | Leukotriene receptor antagonist | Second-generation antihistamine |
| Prescription required? | Yes (prescription only) | No (OTC) |
| FDA-approved for | Asthma, allergic rhinitis, exercise-induced bronchoconstriction | Allergic rhinitis, chronic hives (urticaria) |
| Onset of action | Hours to days for full effect | About 20–60 minutes |
| Typical dosing | Once daily, as directed by a prescriber | Once daily per the OTC label |
| Works on nasal congestion? | Yes (modest effect) | Limited effect |
| Works on asthma? | Yes (add-on/alternative therapy) | No |
| Drowsiness risk | Low | Possible in some people (more than some other 2nd-gen antihistamines) |
| Boxed warning? | Yes — serious neuropsychiatric (mental health) events | No |
| Cost (30-day supply, varies) | ~$10–$30 (generic Rx) | ~$8–$20 (OTC) |
Effectiveness for Allergic Rhinitis
For seasonal and perennial allergic rhinitis, most studies favor antihistamines like cetirizine over montelukast as monotherapy. A meta-analysis in the Annals of Allergy, Asthma & Immunology found that antihistamines are generally at least as effective as leukotriene antagonists for controlling sneezing, runny nose, and itchy eyes. Cetirizine provides faster symptom relief and is effective against histamine-mediated symptoms.
Montelukast may help nasal congestion somewhat, because leukotrienes play a role in nasal swelling. For patients whose main complaint is a stuffy nose, a clinician may consider montelukast or a combination approach — but, given montelukast’s boxed warning (below), guidelines and the FDA favor other options for allergic rhinitis when effective alternatives exist. A once-daily intranasal corticosteroid is another highly effective option for congestion that a clinician or pharmacist can recommend.
Some patients with moderate-to-severe allergic rhinitis are treated with more than one agent. Because montelukast is prescription-only and carries a boxed warning, combining it with an antihistamine is a decision for your prescriber, not a do-it-yourself strategy. The montelukast vs cetirizine question is therefore not always either-or, but any use of montelukast should be individualized and monitored.
Effectiveness for Asthma
This is where the comparison diverges sharply. Cetirizine has no role in treating asthma itself. Montelukast, on the other hand, is FDA-approved as an add-on therapy for asthma and for exercise-induced bronchoconstriction. According to national asthma guidelines (NHLBI/NAEPP), montelukast is considered an alternative — not a first choice — to low-dose inhaled corticosteroids for mild persistent asthma, and it can sometimes be added for patients who need step-up therapy. Inhaled corticosteroids remain the preferred controller for most people.
Montelukast is not a rescue inhaler and does not replace albuterol for acute symptoms. Its role is preventive, reducing baseline airway inflammation to lower the frequency and severity of asthma symptoms over time. Anyone using it for asthma should have an asthma action plan from their clinician.
Side Effects Comparison
Cetirizine Side Effects
Cetirizine is generally well tolerated. Its most notable side effect is drowsiness, which affects a minority of users — clinical data cite roughly 14% of adults and about 4% of children at standard doses — somewhat more than some other second-generation antihistamines like loratadine or fexofenadine. Other common side effects include dry mouth, headache, and fatigue. Serious side effects are uncommon. Because it can cause drowsiness in some people, use caution with driving or operating machinery until you know how it affects you, and be aware that alcohol can add to drowsiness. Cetirizine carries no boxed warning and has a long-established safety record, but read the OTC label and ask a pharmacist if you have questions.
Montelukast Side Effects and the FDA Boxed Warning
Montelukast’s safety profile changed significantly in March 2020, when the FDA added a boxed warning — its strongest warning — for serious mental health (neuropsychiatric) side effects. These can include agitation, aggression, depression, suicidal thoughts and actions, hallucinations, sleep disturbances including sleepwalking, and anxiety. While such events are considered uncommon, the FDA strengthened the warning after post-marketing reports and concluded that many patients and caregivers were not adequately informed of these risks.
The FDA now advises that montelukast should generally be reserved for patients who have not responded adequately to, or cannot tolerate, other therapies — and it specifically advises against using it for mild allergic rhinitis when safer options exist. This is a meaningful shift from earlier prescribing patterns. Patients, parents, and caregivers should watch for and promptly report any new or worsening mood or behavior changes to the prescriber, and seek urgent help for thoughts of self-harm. For a detailed breakdown, read our montelukast side effects guide. Common non-psychiatric side effects can include headache, abdominal pain, and upper respiratory symptoms.
Safety callout: Montelukast is prescription-only — do not start, stop, or change it on your own. If you or someone you care for is taking montelukast and experiences agitation, depression, unusual behavior, or thoughts of self-harm, contact the prescriber promptly; for a mental health emergency call or text 988, and call 911 for immediate danger. For a suspected overdose of any medication, call Poison Control at 1-800-222-1222 (poison.org).
Who Should Use Which Medication?
Cetirizine is a reasonable first-line, self-care choice for many people with straightforward allergy symptoms. It is effective, fast-acting, available without a prescription, affordable, and has a well-established safety record. It is used in adults and children (the OTC label generally covers ages 2 and up; use in younger children should be directed by a clinician). Follow the label, and check with a pharmacist if you take other medicines or have health conditions.
Montelukast is best reserved, under a prescriber’s direction, for specific situations — for example, patients with asthma (often alongside inhaled corticosteroids), exercise-induced bronchoconstriction, or allergy symptoms that have not responded to antihistamines and intranasal corticosteroids. Given the boxed warning, clinicians are now more cautious about prescribing montelukast solely for allergic rhinitis when effective alternatives exist, and they weigh the benefits against the neuropsychiatric risks for each patient.
Frequently Asked Questions
Can I take montelukast and cetirizine together?
They act on different pathways and are sometimes used together, and no significant drug interaction is expected. However, montelukast is prescription-only and carries a boxed warning, so combining them should be decided and monitored by your prescriber rather than started on your own.
Is montelukast stronger than cetirizine?
“Stronger” is not the right comparison, because they work on different inflammatory mediators. For typical allergy symptoms like sneezing and itching, cetirizine is generally more effective. For asthma-related symptoms, montelukast has a role that cetirizine does not. They address different pieces of the allergic response.
Should I stop montelukast because of the boxed warning?
Do not stop any prescription medication without consulting your prescriber. The boxed warning means montelukast should be prescribed more selectively and monitored closely, not that every current user must stop. If it is controlling your asthma and you are not experiencing mental health side effects, your clinician may decide the benefits outweigh the risks. If you notice mood changes, unusual behavior, or sleep disturbances, contact your prescriber promptly.
Does cetirizine work right away while montelukast takes days?
Cetirizine typically provides noticeable relief within about 20–60 minutes and reaches peak effect within a couple of hours. Montelukast may provide some benefit within a day, but its full anti-inflammatory effect can take several days of consistent use as directed by a prescriber.
The Bottom Line
For straightforward allergic rhinitis, cetirizine is an accessible, fast-acting OTC option that is reasonable to try first for many people. Montelukast fills a narrower niche — mainly for patients with asthma or exercise-induced bronchoconstriction, or allergies that do not respond to antihistamines and nasal steroids — and it is prescription-only for good reason. The FDA’s boxed warning does not make montelukast a “bad” medication, but it makes careful, individualized prescribing and ongoing monitoring essential. Talk with your doctor or pharmacist about which approach makes sense for your specific allergy and respiratory profile, and never adjust a prescription medication on your own.
This article is general educational information, not medical advice, and it is not a dosing guide. Cetirizine is an over-the-counter antihistamine — follow the label. Montelukast is prescription-only and carries an FDA boxed warning for serious neuropsychiatric events; only a prescriber can decide whether it is appropriate, and patients and caregivers should promptly report mood or behavior changes. Do not start, stop, or change any medication on your own. Call Poison Control at 1-800-222-1222 for a suspected overdose, 988 for a mental health crisis, and 911 for an emergency.
Sources
- FDA — “FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair)” (March 2020)
- MedlinePlus — Cetirizine; Montelukast drug information
- Mayo Clinic — Allergy medications: know your options
- NHLBI / NAEPP — Guidelines for the diagnosis and management of asthma
- Annals of Allergy, Asthma & Immunology — antihistamines vs leukotriene antagonists in allergic rhinitis
